Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Pathol Int ; 51(10): 792-6, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11881732

RESUMO

Leydig cell tumors of the testis are rare, mostly presenting as a testicular mass or as endocrinological symptoms. Here, three patients who were admitted for investigation of primary infertility and one patient presenting with a testicular mass are reported. The histological features were reviewed and an immunohistochemical study was done using a panel of antibodies against cytokeratin, vimentin, inhibin A, S-100, Ki-67, follicle-stimulating hormone, luteinizing hormone, prolactin, p53, bcl-2, and c-erbB2. The latter case (lost during follow up of metastatic disease) demonstrated massive tumor necrosis, extension through the tunica albuginea, and a high mitotic activity and MIB-1 score. Only this malignant case was bcl-2 positive. Of the two oncogenic markers studied, none of the cases were positive for c-erb2, while p53 was positive in more than 50% of cells in the malignant case and in one case of infertility with a large tumor, hemorrhage, focal necrosis and atypical cytological features. We recommend the evaluation of infertile men for Leydig cell tumors, and we believe that a panel of antibodies, including Ki-67, p53 and bcl-2, used for immunohistochemical analysis could be of diagnostic value in the identification of malignant and borderline cases of Leydig cell tumor.


Assuntos
Tumor de Células de Leydig/patologia , Oligospermia/patologia , Neoplasias Testiculares/patologia , Adulto , Antígenos de Neoplasias/metabolismo , Biomarcadores Tumorais/metabolismo , Divisão Celular , Evolução Fatal , Humanos , Técnicas Imunoenzimáticas , Tumor de Células de Leydig/metabolismo , Tumor de Células de Leydig/cirurgia , Masculino , Pessoa de Meia-Idade , Oligospermia/etiologia , Proteínas Proto-Oncogênicas c-bcl-2 , Neoplasias Testiculares/metabolismo , Neoplasias Testiculares/cirurgia , Proteína Supressora de Tumor p53/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA